Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs. (2nd December 2021)
- Record Type:
- Journal Article
- Title:
- Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs. (2nd December 2021)
- Main Title:
- Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs
- Authors:
- Ricci, Giovanna
Busardò, Francesco Paolo
Gibelli, Filippo
Sirignano, Ascanio
Brunetti, Pietro - Abstract:
- ABSTRACT: Introduction: GHB is a small molecule and is present in the human CNS. Exogenously, GHB is administered orally in the form of sodium oxybate to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy, and to manage alcohol withdrawal and detoxification in alcoholics. GHB shows a biphasic effect and dose-dependent pharmacokinetics and may interact with neuronal systems different from GABAergic one. The compound is also highly abused among bodybuilders and is associated with drugs of abuse. Areas covered: This article provides an overview of the risks associated with the recreational consumption of GHB and its analogues, including pharmaceuticals mostly encountered in GHB-related emergency department admissions and postmortem investigations. A literature search was performed using PubMed, Scopus, Google Scholar, and Web of Science databases to identify scientific reports concerning the recreational use of GHB and analogs with prescribed drugs. Further articles were retrieved after consulting international health and regulatory authorities' reports. Expert opinion: Due to its dual nature, interpreting and distinguishing GHB concentrations in biological fluid represents a challenge in forensic toxicology. To demonstrate recent exposure, a quick collection of samples is necessary to maximize the chance of detecting an exogenous GHB intake, especially in cases of GHB-facilitated sexual assaults.
- Is Part Of:
- Expert opinion on drug metabolism and toxicology. Volume 17:Number 12(2021)
- Journal:
- Expert opinion on drug metabolism and toxicology
- Issue:
- Volume 17:Number 12(2021)
- Issue Display:
- Volume 17, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 17
- Issue:
- 12
- Issue Sort Value:
- 2021-0017-0012-0000
- Page Start:
- 1445
- Page End:
- 1454
- Publication Date:
- 2021-12-02
- Subjects:
- Drug–drug interaction -- GHB -- GBL -- poisoning -- prescribed drugs -- recreational use -- sodium oxybate
Drugs -- Toxicology -- Periodicals
Drugs -- Metabolism -- Periodicals
615.7 - Journal URLs:
- http://www.tandfonline.com/loi/iemt20#.VxdRulL2aic ↗
http://www.expertopin.com/loi/emt ↗
http://www.ingentaconnect.com/content/apl/emt ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17425255.2021.2029404 ↗
- Languages:
- English
- ISSNs:
- 1742-5255
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002943
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21138.xml